{"id":"https://openalex.org/W1495878550","doi":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","title":"Sudden unexpected death in epilepsy in lamotrigine randomized\u2010controlled trials","display_name":"Sudden unexpected death in epilepsy in lamotrigine randomized\u2010controlled trials","publication_year":2012,"publication_date":"2012-10-02","ids":{"openalex":"https://openalex.org/W1495878550","doi":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","mag":"1495878550","pmid":"https://pubmed.ncbi.nlm.nih.gov/23030403"},"language":"en","primary_location":{"id":"doi:10.1111/j.1528-1167.2012.03689.x","doi":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2012.03689.x","source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2012.03689.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019416797","display_name":"Torbj\u00f6rn Tomson","orcid":"https://orcid.org/0000-0003-0554-5352","observed_orcids":["https://orcid.org/0000-0003-0554-5352"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Torbj\u00f6rn Tomson","raw_affiliation_strings":["Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081748468","display_name":"Lawrence J. Hirsch","orcid":"https://orcid.org/0000-0002-6333-832X","observed_orcids":["https://orcid.org/0000-0002-6333-832X"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence J. Hirsch","raw_affiliation_strings":["Department of Neurology and Comprehensive Epilepsy Center, Yale University, New Haven, Connecticut, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Comprehensive Epilepsy Center, Yale University, New Haven, Connecticut, U.S.A","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071565453","display_name":"Daniel J. Friedman","orcid":"https://orcid.org/0000-0003-1068-1797","observed_orcids":["https://orcid.org/0000-0003-1068-1797","https://orcid.org/0000-0002-3442-7454"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Friedman","raw_affiliation_strings":["New York University Comprehensive Epilepsy Center, New York, NY, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Comprehensive Epilepsy Center, New York, NY, U.S.A","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075406050","display_name":"Nicolette Bester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicolette Bester","raw_affiliation_strings":["GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072719649","display_name":"Anne E. Hammer","orcid":"https://orcid.org/0000-0003-0217-3848","observed_orcids":["https://orcid.org/0000-0003-0217-3848"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Hammer","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109159919","display_name":"Michael C. Irizarry","orcid":"https://orcid.org/0000-0002-0246-2511","observed_orcids":["https://orcid.org/0000-0002-0246-2511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Irizarry","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047136661","display_name":"Lianna Ishihara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lianna Ishihara","raw_affiliation_strings":["GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010255066","display_name":"Alok Krishen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alok Krishen","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087974983","display_name":"Theodore C. Spaulding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theodore Spaulding","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000040594","display_name":"Art Wamil","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Art Wamil","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111426332","display_name":"Robert A. Leadbetter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Robert Leadbetter","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina, U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5111426332"],"corresponding_institution_ids":[],"apc_list":{"value":4360,"currency":"USD","value_usd":4360},"apc_paid":null,"fwci":1.9478,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.83469044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"54","issue":"1","first_page":"135","last_page":"140"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sudden-unexpected-death-in-epilepsy","display_name":"sudden unexpected death in epilepsy","score":0.9940000176429749},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.949999988079071},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9610000252723694},{"id":"https://openalex.org/keywords/sudep-risk","display_name":"SUDEP risk","score":0.8999999761581421},{"id":"https://openalex.org/keywords/randomized-controlled-trials","display_name":"randomized controlled trials","score":0.6660000085830688},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5529999732971191},{"id":"https://openalex.org/keywords/tonic-clonic-seizures","display_name":"tonic-clonic seizures","score":0.7609999775886536},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.7120000123977661},{"id":"https://openalex.org/keywords/confounding","display_name":"confounding","score":0.4560000002384186},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8534801006317139},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.8201441764831543},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6605011224746704},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.634583592414856},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6298855543136597},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5737553834915161},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5478477478027344},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.49986839294433594},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.48692381381988525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4444771707057953},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37085533142089844},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.13863080739974976},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D003645","descriptor_name":"Death, Sudden","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003645","descriptor_name":"Death, Sudden","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016001","descriptor_name":"Confidence Intervals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1528-1167.2012.03689.x","doi":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2012.03689.x","source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},{"id":"pmid:23030403","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23030403","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1528-1167.2012.03689.x","doi":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1528-1167.2012.03689.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2012.03689.x","source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1495878550.pdf","grobid_xml":"https://content.openalex.org/works/W1495878550.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W1513838333","https://openalex.org/W1524327358","https://openalex.org/W1549808427","https://openalex.org/W1682534765","https://openalex.org/W1976748501","https://openalex.org/W1978857747","https://openalex.org/W1992399390","https://openalex.org/W2012276882","https://openalex.org/W2016810031","https://openalex.org/W2056897142","https://openalex.org/W2089125052","https://openalex.org/W2100857624","https://openalex.org/W2104068216","https://openalex.org/W2110926310","https://openalex.org/W2119181594","https://openalex.org/W2131979832"],"related_works":["https://openalex.org/W4316928269","https://openalex.org/W2056897142","https://openalex.org/W1682534765","https://openalex.org/W2436652785","https://openalex.org/W807691172","https://openalex.org/W4394887992","https://openalex.org/W1524327358","https://openalex.org/W1513838333","https://openalex.org/W1589779343","https://openalex.org/W2119181594"],"abstract_inverted_index":{"PURPOSE:":[0],"Nonrandomized":[1],"studies":[2],"of":[3,6,38,83,91,112,155,190,235],"the":[4,36,195,243],"relationship":[5],"antiepileptic":[7],"drugs":[8],"(AEDs)":[9],"with":[10,40],"sudden":[11],"unexpected":[12],"death":[13],"in":[14,49,66,180,233],"epilepsy":[15],"(SUDEP)":[16],"may":[17],"be":[18,253],"susceptible":[19],"to":[20,44,106,184],"confounding":[21],"by":[22,55,96],"tonic-clonic":[23],"seizure":[24],"frequency,":[25],"polypharmacy,":[26],"and":[27,47,60,86,147,192,215,239,247],"other":[28],"potential":[29],"risk":[30,37,111],"factors":[31],"for":[32,122,158,176,188],"SUDEP.":[33],"We":[34],"evaluated":[35],"SUDEP":[39,116,157,179,236],"lamotrigine":[41],"(LTG)":[42],"compared":[43,118],"active":[45],"comparators":[46],"placebo":[48],"randomized":[50,68,107],"controlled":[51],"clinical":[52,69,98],"trials":[53],"conducted":[54],"GlaxoSmithKline":[56],"(GSK)":[57],"between":[58,119,237],"1984":[59],"2009.":[61],"METHODS:":[62],"Among":[63],"7,774":[64],"subjects":[65],"42":[67],"trials,":[70],"there":[71],"were":[72,87,93,104,140,144,149,194,245],"39":[73],"all-cause":[74],"deaths.":[75],"Ten":[76],"deaths":[77,92],"occurred":[78],">2":[79],"weeks":[80],"after":[81],"discontinuation":[82],"study":[84],"medication":[85],"excluded.":[88,254],"Narrative":[89],"summaries":[90],"independently":[94],"reviewed":[95],"three":[97],"experts":[99],"(TT,":[100],"LH,":[101],"DF),":[102],"who":[103],"blinded":[105],"treatment":[108,120],"arm.":[109],"The":[110,151,172],"definite":[113],"or":[114],"probable":[115],"was":[117,160,228],"arms":[121,182],"each":[123],"trial":[124],"type":[125],"(placebo-controlled,":[126],"active-comparator,":[127,206],"crossover),":[128],"using":[129],"exact":[130],"statistical":[131],"methods.":[132],"KEY":[133],"FINDINGS:":[134],"Of":[135],"29":[136],"on-treatment":[137],"deaths,":[138],"eight":[139],"definite/probable":[141,156,178],"SUDEP,":[142,146],"four":[143],"possible":[145],"17":[148],"non-SUDEP.":[150],"overall,":[152],"unadjusted":[153],"rate":[154,234],"LTG":[159,181,238],"2.2":[161],"events":[162],"per":[163],"1,000-patient":[164],"years":[165],"(95%":[166,200,209,220],"confidence":[167],"interval":[168],"[95%":[169],"CI]":[170],"0.70-5.4).":[171],"odds":[173],"ratios":[174],"(OR)":[175],"on-treatment,":[177],"relative":[183],"comparator":[185,240],"arms,":[186],"adjusted":[187],"length":[189],"exposure":[191],"trial,":[193],"following:":[196],"placebo-controlled,":[197],"OR":[198,207,218],"0.22":[199],"CI":[201,210,221],"0.00-3.14;":[202],"p":[203,212,223],"=":[204,213,224],"0.26);":[205],"2.18":[208],"0.17-117;":[211],"0.89);":[214],"placebo-controlled":[216],"cross-over,":[217],"1.08":[219],"0.00-42.2;":[222],"1.0).":[225],"SIGNIFICANCE:":[226],"There":[227],"no":[229],"statistically":[230],"significant":[231],"difference":[232],"groups.":[241],"However,":[242],"CIs":[244],"wide":[246],"a":[248],"clinically":[249],"important":[250],"effect":[251],"cannot":[252]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}